Evidence map›Paper›PMID 12700245›Full record

ReviewJournal of bacteriology2003

Microorganisms and cancer: quest for a therapy.

A M Chakrabarty

Abstract readReview
In one paragraph

Review in Journal of bacteriology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Current advances in microbial-based cancer therapies.Medical oncology (Northwood, London, England) · 2023
    Review
  5. Review
  6. Article
  7. Review
  8. Vaccines · 2020
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Leishmanial sphingolipid induces apoptosis in Sarcoma 180 cancer cells through regulation of tumour growth via angiogenic switchover.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  18. Review
  19. Challenges to Improve the Stability and Efficacy of an Intravesical BCG Product.Iranian journal of pharmaceutical research : IJPR · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

A M ChakrabartyDepartment of Microbiology & Immunology, University of Illinois, College of Medicine, Chicago 60612, USA. pseudomo@uic.edu

Funding

MICROBIAL DEGRADATION OF AGENT ORANGER01ES004050 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CHAKRABARTY, ANANDA MOHAN · 1986 to 2004
$1.5M
NIEHS NIH HHS ES-04050-17NIEHS NIH HHS R01 ES004050
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BacteriaAnimalsAntineoplastic AgentsBacterial ProteinsBacterial VaccinesBiological TherapyHumansNeoplasmsAntineoplastic AgentsBacterial ProteinsBacterial Vaccines

Identifiers

PMID12700245
PMCPMC154404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.